Topics

Intrathecal Zolgensma Shows Early Efficacy in SMA

20:00 EDT 25 Mar 2020 | Neurology Times

Nearly all patients in this cohort achieved a clinically meaningful >3-point increase during the study period, demonstrating a consistent response to the gene therapy.  

Original Article: Intrathecal Zolgensma Shows Early Efficacy in SMA

NEXT ARTICLE

More From BioPortfolio on "Intrathecal Zolgensma Shows Early Efficacy in SMA"

Quick Search

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...